Illumina Q3 Earnings Call Highlights

Illumina NASDAQ: ILMN reported third-quarter results above its prior guidance, citing strong clinical sequencing demand, elevated NovaSeq X instrument placements and disciplined spending. The company raised its full-year revenue, operating-margin and earnings outlook, while executives said they remain on track toward longer-term growth targets.

MarketBeat • an hour ago

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2026

SAN DIEGO, Oct. 29, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the third quarter of fiscal year 2026. Third quarter 2026 results Reported revenue was $1.13 billion for Q3 2026, up 4.2% from Q3 2025.

PRNewsWire • 3 hours ago

Illumina (ILMN) Q3 Earnings Beat Estimates

Illumina (ILMN) came out with quarterly earnings of $1.44 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.34 per share a year ago.

Zacks Investment Research • an hour ago

Diamond Hill Small-Mid Cap Fund Q3 2026 Contributors And Detractors

The Fund declined 4.75% while the Russell 2500 Index declined 6.37%. Key contributors include Illumina, Revvity and Waystar. Key detractors include Regal Rexnord, Knife River and Red Rock Resorts.

Seeking Alpha • 16 hours ago

Illumina (ILMN) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Evaluate the expected performance of Illumina (ILMN) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks Investment Research • Oct 28, 2026

Brown Advisory Flexible Equity Strategy: Q3 2026 Top Contributors And Detractors

Microsoft Corporation was the portfolio's top contributor during the quarter. Suncor Energy outperformed the Index during the quarter. KLA Corporation traded lower during the quarter.

Seeking Alpha • Oct 28, 2026

Illumina To Webcast Upcoming Investor Conference

SAN DIEGO, Oct. 27, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investor conference: Upcoming Investor Conference Jefferies Global Healthcare Conference on November 17, 2026 The fireside chat is scheduled for 02:30am PT (10:30am GMT). The webcast can be accessed through the Events & Presentations section of Illumina's website at investor.illumina.com.

PRNewsWire • Oct 27, 2026

Moderna's Rally May Have Run Out of Steam. Here's What to Watch Next

Moderna's stock has taken a big hit that could signal the end of this year's cancer vaccine-driven rally. It may not be too late to play the forces behind its rise.

Investopedia • Oct 26, 2026

ILMN Q3 Earnings Preview: Strong Clinical Demand May Lift Performance

Illumina's Q3 results may benefit from strong clinical demand, NovaSeq X adoption, instrument placements and innovations despite persistent weakness in research markets.

Zacks Investment Research • Oct 22, 2026

Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth

Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Oct 22, 2026